Richard Francis, Teva Pharmaceuticals CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings report.

Teva Pharmaceutical Industries reported a better than expected increase in second-quarter profit on Wednesday, helped by a 26 ...

Teva’s chief drug Austedo—approved in Huntington’s disease and tardive dyskinesia—grew sales 19% to $498 million for the ...

Teva Pharmaceuticals' business and stock price have been declining for years, but there are hints that a turnaround is in progress. Contrarian investors who buy in now have the potential to ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. TEVA, said Monday that it has reached an agreement with the U.S. Department of Justice to settle criminal price-fixing ...

Teva Pharmaceuticals TEVA -0.18% will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal law that prohibits the payment of ...

"Teva Pharmaceuticals USA and others misled the American people about the true dangers of opioids," Attorney General Letitia James, a Democrat, said in a news release.

Topline Teva Pharmaceuticals will shell out as much as much as $523 million in New York to settle claims that the company contributed to the opioid crisis that has killed nearly half a million ...

“Teva Pharmaceuticals USA and others misled the American people about the true dangers of opioids, which is why, in 2019, I made a promise that our team would hold them and the other ...